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Impact of short-term exercise training intensity on β-cell function in older obese 
adults with prediabetes 
Abstract 
The effect of work-matched exercise intensity on β-cell function is unknown in people with prediabetes 
before clinical weight loss. We determined if short-term moderate continuous (CONT) vs. high-intensity 
interval (INT) exercise increased β-cell function. Thirty-one subjects (age: 61.4 ± 2.5 yr; body mass index: 
32.1 ± 1.0 kg/m2) with prediabetes [American Diabetes Association criteria, 75-g oral glucose tolerance 
test (OGTT)] were randomized to work-matched CONT (70% HRpeak) or INT (3 min 90% HRpeak and 3 min 
50% HRpeak) exercise for 60 min/day over 2 wk. A 75-g 2-h OGTT was conducted after an overnight fast, 
and plasma glucose, insulin, C-peptide, and free fatty acids were determined for calculations of skeletal 
muscle [oral minimal model (OMM)], hepatic (homeostatic model of insulin resistance), and adipose 
(Adipose-IR) insulin sensitivity. β-Cell function was defined from glucose-stimulated insulin secretion 
(GSIS, deconvolution modeling) and the disposition index (DI). Glucagon-like polypeptide-1 [GLP-1(active)] 
and glucose-dependent insulinotropic polypeptide (GIP) were also measured during the OGTT, along with 
peak oxygen consumption and body composition. CONT and INT increased skeletal muscle- but not 
hepatic- or adipose-derived DI (P < 0.05). Although both treatments tended to reduce fasting 
GLP-1(active) (P = 0.08), early phase GLP-1(active) increased post-CONT and INT training (P < 0.001). 
Interestingly, CONT exercise increased fasting GIP compared with decreases in INT (P = 0.02). Early and 
total-phase skeletal muscle DI correlated with decreased total glucose area under the curve (r = −0.52, P = 
0.002 and r = −0.50, P = 0.003, respectively). Independent of intensity, short-term training increased 
pancreatic function adjusted to skeletal muscle in relation to improved glucose tolerance in adults with 
prediabetes. Exercise also uniquely affected GIP and GLP-1(active). Further work is needed to elucidate 
the dose-dependent mechanism(s) by which exercise impacts glycemia. 
NEW & NOTEWORTHY Exercise is cornerstone for reducing blood glucose, but whether high-intensity 
interval training is better than moderate continuous exercise is unclear in people with prediabetes before 
weight loss. We show that 2 wk of exercise training, independent of intensity, increased pancreatic 
function in relation to elevated glucagon-like polypeptide-1 secretion. Furthermore, β-cell function, but not 
insulin sensitivity, was also correlated with improved glucose tolerance. These data suggest that β-cell 
function is a strong predictor of glycemia regardless of exercise intensity. 
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ABSTRACT  40 
The effect of work-matched exercise intensity on β-cell function is unknown in people with 41 
prediabetes prior to clinical weight loss. We determined if short-term moderate continuous (CONT) 42 
versus high intensity interval (INT) exercise increased β-cell function. Thirty-one subjects (Age: 43 
61.4±2.5 yr; BMI: 32.1±1.0 kg/m2) with prediabetes (ADA criteria, 75g OGTT) were randomized to 44 
work-matched CONT (70% HRpeak) or INT (3 min 90% HRpeak and 3 min 50% HRpeak) exercise 45 
for 60min/d over 2-weeks. A 75g 2 hr OGTT was conducted after an overnight fast, and plasma 46 
glucose, insulin, C-peptide and FFA were determined for calculations of skeletal muscle (Oral 47 
Minimal Model; OMM), hepatic (HOMA-IR), and adipose (Adipose-IR) insulin sensitivity. β-cell 48 
function was defined from glucose-stimulated insulin secretion (GSIS, deconvolution modeling) and 49 
the disposition index (DI). GLP-1(active) and GIP were also measured during the OGTT, along with 50 
VO2peak and body composition. CONT and INT increased skeletal muscle, but not hepatic or 51 
adipose, derived DI (P<0.05). Although both treatments tended to reduce fasting GLP-1(active) 52 
(P=0.08), early phase GLP-1(active) increased post-CONT and INT training (P<0.001). 53 
Interestingly, CONT exercise increased fasting GIP compared with decreases in INT (P=0.02).  Early 54 
and total phase skeletal muscle DI correlated with decreased total glucose area under the curve (r=-55 
0.52, P=0.002 and r=-0.50, P=0.003, respectively). Independent of intensity, short-term training 56 
increased pancreatic function adjusted to skeletal muscle in relation to improved glucose tolerance in 57 
adults with prediabetes. Exercise also uniquely affected GIP and GLP-1(active). Further work is 58 
needed to elucidate the dose-dependent mechanism(s) by which exercise impacts glycemia.  59 
KEY WORDS: pancreatic function, insulin sensitivity, glucose tolerance, type 2 diabetes, high 60 
intensity interval training 61 
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NEW & NOTEWORTHY 65 
Exercise is cornerstone for reducing blood glucose, but whether high intensity interval training is 66 
better than moderate continuous exercise is unclear in people with prediabetes prior to weight loss. 67 
We show that 2-weeks of exercise training, independent of intensity, increased pancreatic function in 68 
relation to elevated GLP-1 secretion. Further, β-cell function, but not insulin sensitivity, was also 69 
correlated with improved glucose tolerance. These data suggest that β-cell function is a strong 70 
predictor of glycemia regardless of exercise intensity.  71 
 72 
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INTRODUCTION 90 
Maintaining the capacity of β-cells to secrete adequate amounts of insulin in response to low multi-91 
organ insulin sensitivity is paramount to preventing the progression from prediabetes to type 2 92 
diabetes (6). Habitual exercise is established to reduce oral glucose-stimulated insulin secretion 93 
(GSIS) and preserve pancreatic function (3, 7, 16, 20, 34). However, GSIS is influenced by the 94 
prevailing level of multi-organ insulin sensitivity. This is clinically important because the product of 95 
GSIS and insulin sensitivity (i.e. disposition index) is considered a better predictor of future diabetes 96 
development than insulin sensitivity alone (1, 27, 38). Thus, work is required to determine how to 97 
optimize β-cell function. 98 
 99 
It is critical to determine the optimal dose at which exercise affects pancreatic function in people 100 
with prediabetes since they have lost upwards of 80% of their β-cell function (2, 13, 27, 29). While 101 
exercise confers insulin sensitizing and cardiometabolic benefit (e.g. lower total cholesterol and/or 102 
blood pressure), few studies have specifically been designed to determine the dose of exercise 103 
required to optimize β-cell function (5, 21, 29).  Prior work by some (3, 20), but not all (28), suggests 104 
that exercise volume is more important than intensity for pancreatic function in subjects at risk for 105 
type 2 diabetes, despite some individuals having a blunted insulin secretion adaptation (7, 32, 35). 106 
Nonetheless, high intensity interval exercise training (INT) improves β-cell function when adjusted 107 
to changes in skeletal muscle insulin resistance in adults with obesity (11) and type 2 diabetes (18, 108 
26), and it may yield greater benefit than continuous (CONT) exercise (18). However, training 109 
studies to date examining the effect of INT versus CONT exercise on insulin secretion have been 110 
confounded by significant weight/fat loss (18, 33), thereby making it difficult to determine the 111 
impact of exercise intensity per se on pancreatic function. A recent study by Heiskansen et al. 112 
compared a 2-week sprint interval versus moderate continuous training program in adults with 113 
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prediabetes/type 2 diabetes and reported no difference between exercise intensities on enhancing 114 
pancreatic function (15). A limitation of this prior work though was that the workloads were not 115 
work-matched, only early phase insulin secretion was tested and no assessment of incretin hormones 116 
(i.e. glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like polypeptide-1 (GLP-1)) 117 
were made. Thus, there is a major knowledge gap in determining whether INT exercise enhances 118 
both early and total phase pancreatic function to a greater extent than CONT exercise when matched 119 
on energy expenditure. This is germane in individuals with prediabetes because they have 120 
disturbances in both phases of insulin secretion (17). Based on a recent study we conducted 121 
demonstrating that 2-weeks of work-matched CONT and INT exercise improved glucose tolerance 122 
comparably, but did not relate to insulin sensitivity, in people with prediabetes (12), we tested the 123 
hypothesis that INT and CONT would induce similar benefit to early and total phase β-cell function 124 
in relation to glucose tolerance. We also hypothesized that this increase in β-cell function would 125 
relate to the incretins GIP and GLP-1 following training.  126 
 127 
METHODS 128 
Subjects: These older, obese subjects (Age: 61.4±2.5 yr; BMI: 32.1±1.0 kg/m2) were the same 129 
individuals that were previously reported in our prior randomized-controlled study on glucose 130 
tolerance and metabolic flexibility (12). Subjects were recruited via flyers and/or newspaper 131 
advertisements from the local community. All subjects underwent a 75g oral glucose tolerance test 132 
(OGTT) to determine prediabetes status according to the American Diabetes Association (ADA), 133 
which was defined as either a fasting plasma glucose between 100-125 mg/dl and/or 2 hr glucose 134 
between 140-199 mg/dl (12). Subjects were non-smoking and sedentary (exercise < 60 min/wk) and 135 
underwent medical history and physical examination that included a resting and exercise stress test 136 
with 12-lead electrocardiogram. Blood and urine chemistry analyses were also conducted to exclude 137 
people with known disease (e.g. type 2 diabetes, liver disease, cardiac dysfunction, etc.). Subjects 138 
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were excluded if taking medications considered to impact glycemia (e.g. biguanides, GLP-1 agonists, 139 
etc.). All subjects provided written signed and verbal informed consent as approved by the University 140 
of Virginia Institutional Review Board. 141 
 142 
Body Composition and Aerobic Fitness: Weight was assessed on a digital scale and height was 143 
recorded with a stadiometer to determine body mass index (BMI). Body fat, skeletal muscle mass 144 
(i.e. fat-free mass minus total body water) and visceral fat were measured by bioelectrical impedance 145 
(InBody 770 Analyzer, Cerritos, CA) (8). Subjects completed a continuous incremental peak oxygen 146 
consumption (VO2peak) test using cycle ergometer with indirect calorimetry (Carefusion, Vmax 147 
Encore, Yorba Linda, CA) and heart rate (HR) peak was used to prescribe submaximal exercise.  148 
  149 
Metabolic Control: Subjects were instructed to consume a diet containing about 250 g of 150 
carbohydrates during the 24 hr period prior to the pre-intervention testing. This dietary pattern was 151 
recorded and replicated on the day before post- testing. Three-day food logs, including two weekdays 152 
and one weekend day, were used to assess ad libitum food intake before and after training (ESHA 153 
Research, Version 11.1, Salem, OR). Subjects were also instructed to refrain from alcohol, caffeine, 154 
medication and strenuous physical activity for 24 hr prior to each study visit. Post-intervention 155 
assessments were obtained approximately 24 hr after the last training session.  156 
 157 
Exercise Training: Subjects were randomly assigned to 12, 60 minute/d work-matched bouts of 158 
CONT or INT cycle ergometry exercise over 13 days. A rest day was provided on day 7. CONT 159 
exercise was performed at a constant intensity of 70% HRpeak, whereas INT exercise involved 160 
alternating 3 minute intervals at 90% HRpeak followed by 50% HRpeak. Subsequently, both 161 
interventions were designed to exercise at approximately 70% HRpeak. HR (Polar Electro, Inc. 162 
Woodbury, NY) and rating of perceived exertion (RPE) were monitored throughout training to 163 
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ensure intensity. Exercise energy expenditure was calculated using HR-VO2 regression analysis with 164 
correction for O2 consumption during CONT (n=3) and INT (n=4) from a subset of our group as 165 
previously performed (29).  166 
 167 
Pancreatic β-cell Function: Following an approximate 10 hr fast subjects reported to our Clinical 168 
Research Unit. Subjects rested in a semi-supine position while an intravenous line was placed in the 169 
antecubital vein for blood collection. Blood samples were obtained for the determination of plasma 170 
glucose, insulin, and C-peptide at 0, 30, 60, 90, and 120 minutes. GLP-1(active) and GIP were 171 
collected at 0, 30 and 60 minutes to characterize incretin responses. Fasting free fatty acids (FFA) 172 
was also obtained. Total area under the curve (AUC) during the OGTT was calculated using the 173 
trapezoidal rule as previously performed for GSIS adjustments to multi-organ insulin sensitivity by 174 
our group and others (4, 9, 29, 30). Skeletal muscle insulin sensitivity was calculated using the oral 175 
minimal model (OMM) and hepatic and adipose insulin resistance were estimated by multiplying 176 
fasting glucose and FFA by fasting insulin, respectively (30). Pre-hepatic insulin secretion rate (ISR) 177 
was reconstructed by deconvolution from plasma C-peptide (39). Glucose-stimulated insulin 178 
secretion (GSIS) was calculated as ISR AUC divided by glucose AUC during the OGTT. The early 179 
(0-30 min) and total phase (0-120 minute) disposition index was used to calculate β-cell function 180 
relative to skeletal muscle as AUC of ISR-/glucose divided by 1/OMM. β-cell function adjusted for 181 
hepatic and adipose insulin resistance was also calculated as AUC of ISR/glucose divided by 182 
homeostatic model of insulin resistance (HOMA-IR) or Adipose-IR. Hepatic insulin extraction was 183 
calculated as AUC of C-peptide divided by insulin during the OGTT.  184 
 185 
Biochemical Analysis: Plasma glucose was analyzed by a glucose oxidase assay (YSI Instruments 186 
2700, Yellow Springs, OH).  Remaining samples were centrifuged at 4°C for 10 min at 3000 RPM, 187 
and stored at -80°C until later batched-analyzed in duplicate to minimize variance within conditions. 188 
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Insulin, C-peptide, and FFA vacutainers contained aprotonin, while GLP-1(active) and GIP 189 
vacutainers contained aprotonin and dipeptidyl peptidase-4 (DPP-IV). Insulin, C-peptide, GLP-190 
1(active) (i.e. 7-36 and 7-37 amide) and GIP were measured using an ELISA (Millipore, Billerica, 191 
MA). Plasma FFAs were determined by a colorimetric assay (Wako Chemicals, Richmond, VA).  192 
 193 
Statistical Analysis: Given the relevance of fitness, body composition, glucose, FFA and insulin to 194 
understanding of pancreatic function, these data are reported in text for clarity (12).  Data were 195 
analyzed using R (The R Foundation, Vienna, Austria 2013). Skewed data were log transformed for 196 
statistical analysis to meet normality. Unfortunately, due to technical difficulty some GIP (n=2, 1 197 
Female and 1 Male) and GLP-1 (n=1, Male) data were lost within the CONT treatment. Baseline data 198 
were compared with independent, two-tailed t-tests. Intervention data were compared using a 2-way 199 
(group x test) or 3-way (group x test x time) ANOVA with test as the repeated measures when 200 
appropriate. Pre-test total phase GSIS as well as early and total phase adipose disposition index and 201 
Adipose-IR were different between groups. Thus, these data were used as co-variates when 202 
performing ANOVA. Pearson’s correlation was used to determine associations. Significance was set 203 
at P≤0.05, and data are expressed as mean  SEM. 204 
 205 
RESULTS  206 
Subject Characteristics: Both CONT and INT exercise reduced body weight (-0.3  0.2 vs. -1.0  207 
0.2kg, P<0.01) and skeletal muscle mass (-0.4  0.1 vs. -0.4  0.1kg, P<0.01) (12). However, there 208 
was no difference following CONT or INT training in body fat (0.1  0.1 vs. 0.3  0.2kg, P=0.18; 209 
(12)) or visceral fat (1.1  0.2 vs. 1.1  1.5 cm
2
, P=0.26). VO2peak increased following both CONT 210 
and INT (0.4  0.2 vs. 0.5  0.2 ml/kg/min; P<0.05). Although submaximal HR was approximately 211 
73  1% and 79  1% for CONT and INT, respectively (P<0.01), subjects had similar RPE (12.8  212 
 9 
0.3 vs. 12.2  0.5 a.u.; P=0.23) (12) and exercise energy expenditure (388.3±14.8 vs. 384.5±18.8 213 
kcal/session, P=0.87). There were no dietary intake differences post-training (data not shown)  (12).  214 
 215 
Glucose, FFA, and Insulin Metabolism: CONT and INT training had no effect on fasting (1.0  1.7 216 
vs. -2.1  2.1 mg/dl, P=0.70) or early phase glucose tolerance (Figure 1). However, training reduced 217 
time series glucose levels, as evident by decreased total phase glucose AUC (P=0.03; Figure 1). 218 
Fasting FFA (0.03  0.7 vs. 0.05  0.04 mEq/ml, P=0.15) and insulin levels (-0.4  1.5 vs. 0.1  1.1 219 
U/ml, P=0.89) were not statistically different following CONT or INT (12), although training 220 
reduced early and total-phase insulin AUC following both exercise treatments (P<0.05, Table 1).  221 
 222 
Insulin Sensitivity: Skeletal muscle insulin sensitivity increased following both CONT and INT 223 
(P=0.01, Table 2). Neither hepatic or adipose insulin resistance were altered after the intervention.  224 
 225 
Pancreatic β-cell Function: CONT and INT training had no effect on fasting (P=0.17) or early phase 226 
C-peptide levels, although it did lower total phase AUC (P<0.01, Table 1 and Figure 1). Early and 227 
total phase ISR were also unaltered following CONT and INT treatment. Early phase GSIS was 228 
additionally not significantly changed following either exercise intensity, although CONT training 229 
increased total phase GSIS compared to a slight decrease after INT exercise (P=0.02). Hepatic and 230 
adipose disposition index was not altered following CONT or INT training (Figure 2). However, 231 
both CONT and INT exercise increased early and total phase skeletal muscle disposition index 232 
(P<0.001, Figure 1). Both treatments increased early phase hepatic insulin extraction (P=0.01), 233 
although CONT training decreased clearance during the total phase versus INT exercise (P=0.05, 234 
Table 1) 235 
 236 
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Incretins: Although both interventions tended to reduce fasting GLP-1(active) (P=0.08), training 237 
raised early phase GLP-1(active) in response to the OGTT (P<0.01, Table 1). CONT exercise 238 
increased fasting GIP compared with INT (P=0.05), and there was no effect of training on post-239 
prandial GIP (Table 1).  240 
 241 
Correlational Analysis: Baseline fasting and 2-hr glucose tended to correlate with changes in total 242 
phase β-cell function (r=0.29, P=0.11 and r=0.32, P=0.07, respectively). Enhanced early and total 243 
phase skeletal muscle disposition index was not related to weight loss (r=0.21, P=0.23 and r=0.18, 244 
P=0.32) or increases in VO2peak (r=-0.20, P=0.26 and r=-0.26, P=0.14). Reduced glucose AUC at 245 
120 minutes correlated with increased early (r=-0.52, P=0.002) and total (r=-0.50, P=0.003) phase 246 
skeletal muscle disposition index following short-term training (Figure 3). There was no relation 247 
between glucose AUC at 120 minutes and insulin sensitivity derived from the OMM (r=-0.28, 248 
P=0.12) or early (r=-0.20, P=0.27) and total phase GSIS (r=-0.14, P=0.42). Decreased fasting GIP 249 
correlated with lower fasting C-peptide (r=0.41, P=0.02) and plasma insulin (r=0.50, P=0.005).  250 
 251 
DISCUSSION    252 
This study demonstrates that short-term exercise training increases β-cell function adjusted for 253 
skeletal muscle insulin sensitivity in adults with prediabetes, independent of intensity. Further, only 254 
CONT exercise raised fasting GIP, whereas both CONT and INT increased early phase GLP-1 255 
during the OGTT. The increase in pancreatic function is clinically important as it was directly related 256 
to improved glucose tolerance. Together, these data suggest that exercise promotes unique 257 
compensatory mechanisms between skeletal muscle, gut and pancreas to reduce ambient glucose 258 
concentrations. Although our data confirm the use of high intensity INT exercise to improve glucose 259 
regulation (18, 32), the present data do not support prior work (5, 29, 34) suggesting greater 260 
intensities of exercise training enhance β-cell function above that of lower exercise doses in 261 
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overweight people. In fact, our findings not only support moderate intensity exercise as an effective 262 
program to increase GSIS and induce pancreatic function (34), but also we confirm recent work in 263 
adults with prediabetes and type 2 diabetes that 2 weeks of sprint interval or continuous moderate 264 
intensity exercise induced similar beneficial effects on pancreatic function (21). However, this prior 265 
work was not work-matched between intensities, nor was insulin secretion measured in the early and 266 
total phase adjusted for different indexes of insulin sensitivity to elucidate how multiple organs may 267 
impact glucose disposal. Herein we expand on this prior work and show that when high intensity INT 268 
exercise is calorically matched to moderate CONT training there is a similar rise in early and total 269 
phase pancreatic function when adjusted to skeletal muscle, but not hepatic or adipose, insulin 270 
sensitivity. This is physiologically relevant as the inverse of GSIS and tissue-specific insulin 271 
sensitivity provides an integrated view for whole-body glucose disposal (4, 9, 16, 30).   272 
 273 
Prior work by our group demonstrated that β-cell function was a stronger predictor of glycemic 274 
control benefit following CONT exercise training than insulin sensitivity (35). We confirm these 275 
findings in the present study, and expand upon our recent exercise intensity work (12), by showing 276 
that the capacity to secrete insulin following CONT or INT exercise training may be more important 277 
for glycemic regulation than insulin sensitivity. Importantly, although associations do not equal 278 
causation, improved glucose tolerance was correlated with increased early and total phase β-cell 279 
function. This is consistent with recent work we published showing that INT exercise adds to the 280 
benefit of caloric restriction on glucose tolerance in obese adults through a pancreatic function-281 
skeletal muscle mechanism (11). To that extent, it is recognized that the disposition index is the 282 
product of GSIS and insulin sensitivity. If one of these outcomes related to glucose tolerance, it may 283 
confound the ability to confirm that β-cell function is independently driving glycemic control. 284 
Interestingly, GSIS nor insulin sensitivity correlated with improved glucose tolerance in this report, 285 
thereby highlighting that it is the coordinated capacity to secrete insulin relative to the level of insulin 286 
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sensitivity that is critical for glucose control. Indeed, recent work has postulated that functional high 287 
intensity exercise training (32) or high intensity INT exercise (33), but not moderate intensity 288 
exercise with weight lifting (41), increases the efficiency by which insulin is synthesized in people 289 
with type 2 diabetes and/or metabolic syndrome. We did not design the current study to test the 290 
mechanism by which exercise increases pancreatic function per se, but the present data do support 291 
that in as little as 2 weeks training increases the ability of the pancreas to release of the readily 292 
available pool of insulin (i.e. early phase) and synthesize insulin in response to ambient glucose (i.e. 293 
total phase) in people with prediabetes. Moreover, we note no change in hepatic and/or adipose 294 
disposition index. This is in contrast to prior work by our group showing that a single bout of high 295 
intensity exercise reduces GSIS when adjusted to hepatic and adipose insulin resistance to support 296 
glucose control in the immediate post-exercise period (30). Subjects in the current study, however, 297 
were studied approximately 24 hr following the last exercise bout in order to minimize effects of the 298 
residual exercise bout. As such, our findings suggest that tissues involved in insulin-mediated 299 
glucose regulation play distinct roles to maintain glucose homeostasis over time.   300 
 301 
GLP-1 and GIP are collectively referred to as incretins and regulate nearly 60% of post-prandial 302 
insulin secretion (42). Few exercise training studies have examined gut incretin responses, and none 303 
have tested the effect of intensity in people with prediabetes prior to clinically meaningful weight 304 
loss. Interestingly, prior work using CONT exercise and diet-induced weight loss report increased 305 
pancreatic function in relation to GIP in older, obese adults with prediabetes or type 2 diabetes (19, 306 
36). This is consistent with a recent 7-day CONT high intensity exercise intervention in obese adults 307 
resulting in reduced fasting GLP-1(active) and increased early phase GLP-1(active) in response to an 308 
OGTT (23). We report herein that fasting GLP-1(active) tended to decrease following both CONT 309 
and INT training, but only CONT exercise increased fasting GIP. Furthermore, we noted marked 310 
increases in GLP-1(active) during the early phase of the OGTT following both exercise treatments 311 
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(Table 2). Our findings are consistent with this prior work (23) as well as cross-sectional work 312 
showing that trained individuals have lower fasting GLP-1 compared with untrained counterparts 313 
(24). In contrast, others have reported no change in fasting GLP-1 (25) or GLP-1 and GIP response to 314 
glucose-stimulation (25, 32, 43). Collectively, the rise in fasting GIP from CONT exercise, coupled 315 
with the rise in early phase GLP-1 active after both CONT and INT exercise herein, is consistent 316 
with our observation for the preservation of GSIS in the presence of increased insulin sensitivity as 317 
well as elevated pancreatic function following both treatments in people with prediabetes. Indeed, we 318 
report that the change in fasting GIP was associated with tracking fasting circulating C-peptide and 319 
insulin. The mechanism by which CONT exercise raised GIP versus INT is beyond the scope of this 320 
study, but it may relate to reductions in DPP-IV (28) and/or altered incretin-pancreas sensitivity (37, 321 
43) since we detected no difference in body/visceral fat or aerobic fitness following exercise. 322 
Additional work is warranted to elucidate the mechanism(s) by which exercise dose acts on the 323 
pancreas for precision treatment of glucose control.  324 
 325 
People with prediabetes (29, 34) and type 2 diabetes (7, 36) have been documented to increase β-cell 326 
function following habitual physical activity. In fact, prior work suggests that individuals with low 327 
pre-treatment β-cell function are likely to increase β-cell function following exercise training (29, 328 
34). This later point is clinically relevant, as even small amounts of exercise could benefit β-cell 329 
function (29, 34). However, some have postulated that adults with chronic hyperglycemia or type 2 330 
diabetes have blunted responses to habitual exercise training (7, 22, 35). Herein we show that 331 
baseline fasting and 2-hr glucose levels tended to relate to increased total phase β-cell function after 332 
training. This is consistent with some work by our group (12) and others (40) showing that people 333 
with hyperglycemia derive gluco-regulatory benefit from exercise. Nonetheless, additional work is 334 
required to elucidate how exercise regulates glucose control in different obese phenotypes as well as 335 
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consider the mechanism by which nutrition and/or pharmaceutical intervention alters the exercise 336 
effect on pancreatic function (10, 14, 31). 337 
 338 
Our interpretations may be affected by the limitations of this study. This is a relatively small sample 339 
size without a lean control group. Therefore, it is unclear if our intervention would impact obese 340 
adults with prediabetes across age or have differential training responses to healthy controls. 341 
Individuals undergoing INT exercise had slightly higher percent heart rates during training on 342 
average than CONT exercise. The reason for this likely resides in slowed recovery between high and 343 
low intervals. Nonetheless, this is unlikely to impact our results given comparable energy 344 
expenditures between treatments. Further, we used the OGTT to assess pancreatic function, and it is 345 
possible that this approach did not detect comparable changes in insulin secretion when compared 346 
with intravenous glucose methods. However, use of the OGTT increases the physiologic relevance of 347 
our study and provide “real-world” findings that allows simultaneous assessment of incretins. We 348 
acknowledge use of surrogate measures of liver and adipose insulin resistance may also 349 
underestimate true changes in multi-organ insulin action. However, HOMA-IR and Adipose-IR are 350 
valid approaches to estimate hepatic and adipose insulin resistance, respectively, and have been 351 
previously used by our group and others (4, 9, 30). Nevertheless, we recognize that further work 352 
using stable isotopes to more directly assess skeletal muscle glucose uptake, hepatic glucose 353 
production and lipolytic rate is needed to tease out the role of distinct tissues on pancreatic function. 354 
Early phase hepatic insulin extraction increased during the OGTT, suggesting that circulating insulin 355 
more efficiently cleared following CONT and INT training. However, CONT exercise decreased 356 
total phase hepatic insulin extraction compared with INT. While these differences in insulin and C-357 
peptide may influence calculations of insulin metabolism, the relevance of this observation is unclear 358 
as both exercise treatments reduced total phase glucose, insulin and C-peptide during the OGTT and 359 
pancreatic function was modeled using C-peptide deconvolution. Nonetheless, it highlights that 360 
 15 
exercise likely acts in dose-dependent manner to support glycemia and further work investigating 361 
hepatic insulin extraction is required to understand insulin metabolism post-exercise. 362 
 363 
In conclusion, short-term exercise training increases GSIS when adjusted to skeletal muscle, but not 364 
hepatic or adipose, insulin sensitivity. Independent of intensity, repeated bouts of exercise over 2 365 
weeks increased post-prandial GLP-1(active). However, only CONT exercise increased fasting GIP. 366 
Together, these data indicate that exercise adjusts pancreatic function uniquely between glucose 367 
regulatory tissues to support glycemic control in people with prediabetes. Further work is warranted 368 
to understand the cross-talk between insulin sensitive tissues and the pancreatic β-cells to optimize 369 
treatments that prevent, treat and/or delay the onset of type 2 diabetes.  370 
 371 
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TABLE LEGENDS 575 
 576 
Table 1. Early and Total Phase Insulin Secretion and Incretin Responses before and after training.  577 
Data are expressed as mean  SEM. ^Data log-transformed for statistical analysis. CONT = 578 
continuous exercise. INT = interval exercise. PG = plasma glucose. C-pep = plasma C-peptide. AUC 579 
= total area under the curve. ISR = insulin secretion rate derived from deconvolution of plasma C-580 
peptide. GSIS = glucose-stimulated insulin secretion rate (AUC of ISR divided by Glucose). HIE = 581 
hepatic insulin extraction.  582 
 583 
 584 
 585 
Table 2. Insulin Sensitivity before and after exercise training.  Data are expressed as mean  SEM. 586 
OMM = oral minimal model was calculated from plasma glucose and insulin to measure skeletal 587 
muscle insulin resistance. Homeostatic model of insulin resistance (HOMA-IR) was calculated as 588 
fasting PG x fasting PI then divided by 405 to depict hepatic insulin resistance. Adipose-IR was 589 
calculated as fasting FFA x fasting PI to determine adipose insulin resistance. 590 
 591 
 592 
 593 
 594 
 595 
 596 
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Table 1. Early and Total Phase Insulin Secretion and Incretin Responses before and after training.   597 
 598 
    CONT INT ANOVA              (P-value) 
              Pre Post Pre Post Test G x T 
Fasting       
C-pep (ng/ml) 2.4  0.2 2.2  0.2 2.2  0.2 2.1  0.2 0.17 0.73 
ISR (pM/min) 207.6  19.4 191.9  19.7 239.3  16.9 232.9  23.4 0.31 0.68 
GIP (pg/ml) 58.0  10.2  65.4  15.6 59.5  5.3 46.0  7.0 0.72 0.02 
GLP-1(active) (pg/ml) 7.1  2.2 6.7  1.8 8.6  2.9 7.4  2.4 0.08 0.31 
 
Early-Phase Response 
      
Insulin AUC (U/ml-30min) 1449.6  154.3 1293.3  142.1 1666.2  182.5 1455.6  206.1 0.01 0.70 
C-pep AUC (ng/ml-30min) 135.4 ± 12.6 126.7 ± 11.1 144.7 ± 10.4 140.6 ± 11.2 0.21 0.66 
ISR AUC x 10
-3 (pM/ml-30min) 17.4 1.6 16.5  1.6 18.8  1.2 18.7  1.5 0.47 0.59 
GSIS (pM/min/mg/dl)^ 4.4 ± 0.3 4.3 ± 0.3 4.8 ± 0.3 4.9 ± 0.3 0.88 0.68 
HIE (ng/ml/U/ml-30min) 0.09 ± 0.00 0.11 ± 0.01 0.09 ± 0.01 0.11 ± 0.01 0.01 0.60 
GIP AUC (pg/ml-30min) 5302.2 ± 841.3 5529.7 ± 824.0 6222.01 ± 301.3 6031.2 ± 609.4 0.93 0.49 
GLP-1(active) AUC (pg/ml-30min) 306.7 ± 75.5 339.9 ± 80.9 406.1 ± 77.7 443.8 ± 75.0 <0.001 0.79 
 
Total-Phase Response 
      
Insulin AUC (U/ml-120min) 10200.3  1243.6 9365.7  1208.9 10406.8  1266.4 9288.8  1248.7 0.03 0.75 
C-pep AUC (ng/ml-120min) 1156.9 ± 95.0 946.7 ± 86.7 1159.0 ± 88.1 969.7 ± 65.2 <0.001 0.77 
ISR AUC x 10
-3 (pM/ml-120min) 91.3  11.5 104.2  10.7 108.4  7.7 99.1  7.0 0.69 0.13 
GSIS (pM/min/mg/dl) 4.9 ± 2.5 5.9 ± 1.8   6.2 ± 1.6^ 5.9 ± 1.5 0.06 0.02 
HIE (ng/ml/U/ml-120min) 0.12  0.01 0.10  0.01 0.12  0.01 0.12  0.01 0.05 0.07 
GIP AUC (pg/ml-120min) 13797.2 ± 2040.8 14290.4 ± 1949.7 16555.4 ± 846.8 16035.1 ± 1606.7 0.98 0.46 
GLP-1(active) AUC (pg/ml-120min) 646.7 ± 156.3 649.3 ± 152.9 850.0 ± 151.9 801.2 ± 139.3 0.52 0.44 
 599 
Data are expressed as mean  SEM. CONT = continuous exercise; n = 17 (13 Females) for all outcomes except GIP (n=15, 12 Females) and 600 
GLP-1 (n=16, 13 Females). INT = interval exercise; n = 14 (11 Females). GSIS data were log-transformed for statistical analysis. CONT = 601 
continuous exercise. INT = interval exercise. PG = plasma glucose. C-pep = plasma C-peptide. AUC = total area under the curve. ISR = 602 
insulin secretion rate derived from deconvolution of plasma C-peptide. GSIS = glucose-stimulated insulin secretion rate (AUC of ISR 603 
divided by Glucose). HIE = hepatic insulin extraction. ^Pre-test group difference, P<0.05. 604 
 605 
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Table 2. Insulin Sensitivity before and after exercise training.   606 
 607 
 CONT       INT   ANOVA (P-value) 
 Pre Post Pre  Post       Test      G x T 
OMM 0.00044  0.00009 0.00055  0.00008 0.00033  0.00004 0.00051  0.00008 0.01  0.50 
HOMA-IR 3.5  0.6 3.6  0.6 3.1  0.5 3.0  0.5   0.98   0.63 
Adipose-IR 9.6  1.8 8.6 1.9   7.4  2.1^ 6.8 1.3   0.53   0.99 
 608 
Data are expressed as mean  SEM. CONT = continuous exercise; n = 17 (13 Females). INT = 609 
interval exercise; n = 14 (11 Females). OMM = oral minimal model was calculated from plasma 610 
glucose and insulin to measure skeletal muscle insulin resistance. Homeostatic model of insulin 611 
resistance (HOMA-IR) was calculated as fasting PG x fasting PI then divided by 405 to depict 612 
hepatic insulin resistance. Adipose-IR was calculated as fasting FFA x fasting PI to determine 613 
adipose insulin resistance. 614 
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FIGURE LEGENDS 650 
Figure 1. Impact of exercise intensity on circulating glucose during the OGTT. CONT = continuous 651 
exercise; n = 17 (13 Females). INT = interval exercise; n = 14 (11 Females). Main effect of Test as 652 
well as Time (P<0.05) was observed for circulating glucose post-intervention (CONT, A and INT, 653 
B). Early phase (C) and total phase (D) glucose tolerance were calculated using total area under the 654 
curve (AUC).  *Main effect of Test, P<0.05. 655 
 656 
 657 
Figure 2. Effect of exercise intensity on β-cell function adjusted for multi-organ insulin resistance. 658 
Data are expressed as mean  SEM. CONT = continuous exercise; n = 17 (13 Females). INT = 659 
interval exercise; n = 14 (11 Females), although 1 subject (Female) was removed from CONT and 660 
INT, respectively, for hepatic and adipose DI since they were an outlier (> 2 SD from mean). DI = 661 
disposition index and was used to characterize pancreatic β-cell function. Skeletal muscle DI was 662 
calculated as AUC of ISR/Glucose divided by 1/OMM. Hepatic DI was estimated as AUC of 663 
ISR/Glucose divided by HOMA-IR. Adipose DI was determined as AUC of ISR/Glucose divided by 664 
Adipose-IR. All β-cell function data were log-transformed for statistical analysis, but are shown here 665 
in raw values. *Main effect of Test, P<0.05. ^Pre-test group difference, P<0.05. 666 
 667 
 668 
 669 
Figure 3. β-cell Function correlates with Glucose Tolerance. CONT = continuous exercise; n = 17 670 
(13 Females). INT = interval exercise; n = 14 (11 Females). Glucose-stimulated insulin secretion rate 671 
(C-peptide deconvolution) AUC was divided by glucose AUC during the OGTT. Early (A; 0-30 min) 672 
and total phase (B; 0-120 minute) β-cell function, or disposition index, relative to skeletal muscle 673 
was calculated as AUC of ISR-/glucose divided by 1/oral minimal model (OMM). Closed circle = 674 
CONT and Open circle = INT. 675 
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